56
Participants
Start Date
October 19, 2023
Primary Completion Date
March 30, 2025
Study Completion Date
May 1, 2025
Patient-led Insulin (intervention group)
Individuals randomized to this arm will initiate night-time insulin of 10 units. The type of basal insulin will be left to the discretion of the provider with levemir or glargine preferred over NPH. On day 0 of initiation of insulin, the patient will initiate night-time (or prior to sleep if alternate sleep schedule) insulin of 10 units (glargine, detemir, or NPH). Patient will check their fasting blood glucose in the morning and record their values. If the value is below 70 they will decrease their insulin dosage that night by 2 units; if the value is above 95 they will increase their insulin dosage that night by 2 units; and if the value is between 70 and 95, they will maintain the same insulin dosage that night. The patients will continue this algorithm for the remainder of the pregnancy. If the patient does not have a fasting blood glucose, the patient will maintain the dose of basal insulin at the prior dose.
Provider-led Insulin (standard care)
Individuals randomized to this arm will receive standard care and titration of insulin will be determined by the individual providers.
The Ohio State University Wexner Medical Center OB/GYN Maternal and Fetal Medicine, Columbus
Ohio State University
OTHER